Biopharmaceutical companies, Alvotech and Prestige Biopharma, have announced in an Aug. 27, 2019 press release the formation of a new contract manufacturing partnership for the commercial production of a biosimilar.
Prestige Brands Holdings Receives FDA Warning Letter